Tyra Biosciences, Inc. (TYRA) Financial Statements
Free cash flow over the same period: -$109.9M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
TYRATyra Biosciences, Inc.Follow TYRA — free
—
Price chart with a free account
- Market cap
- 1.2B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Research & development | 20.6 | 43.0 | 62.5 | 80.1 | 102.9 | 126.3 | |
| Operating income | -26.3 | -58.9 | -79.9 | -104.2 | -132.8 | -160.5 | |
| Pre-tax income | -26.3 | -55.3 | -69.1 | -86.5 | -119.9 | -148.6 | |
| Income tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Net income | -26.3 | -55.3 | -69.1 | -86.5 | -119.9 | -148.6 | |
| Diluted EPS ($) | -1.91 | -1.32 | -1.62 | -1.51 | -2.01 | -2.39 | |
| Diluted shares (mn) | — | 41.9 | 42.7 | 57.2 | 59.6 | — |
USD millions · SEC XBRL
Tyra Biosciences, Inc. — questions
- What is Tyra Biosciences, Inc.'s net income?
- -$148.6M over the twelve months to 2026-06-30.
- What is Tyra Biosciences, Inc.'s free cash flow?
- -$109.9M over the twelve months to 2026-06-30.
- What are Tyra Biosciences, Inc.'s diluted earnings per share?
- $-2.39 over the twelve months to 2026-06-30.
Every figure on this page comes from Tyra Biosciences, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.